Omega Therapeutics, Inc. (OMGA) Misses Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St rises as Anthropic's IPO filing sharpens focus on AI trade
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mail
Get Alerts OMGA Hot Sheet
Join SI Premium – FREE
Omega Therapeutics, Inc. (NASDAQ: OMGA) reported Q2 EPS of ($0.54), $0.04 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $760 thousand versus the consensus estimate of $378.57 thousand.
For earnings history and earnings-related data on Omega Therapeutics, Inc. (OMGA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Highlights Top Shopping Center REITs Ahead of Q3 Earnings
- CVR Energy stock climbs ahead of earnings report
- Bank Of Marin Bancorp (BMRC) Tops Q3 EPS by 5c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
